SCHEMBL20028883

SCHEMBL20028883

N#Cc1ccnc(-c2ccc3oc(C4(F)CCCN(C#N)C4)nc3c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29679748 1.00 USP30 (1.00) USP30
SCHEMBL29679891 1.00 USP30 (1.00) USP30
SCHEMBL20028882 1.00 USP30 (1.00) USP30
SCHEMBL29679586 0.86 USP30 (1.00) USP30
SCHEMBL21145344 0.86 USP30 (1.00) USP30
SCHEMBL20028996 0.86 USP30 (1.00) USP30
SCHEMBL21145357 0.86 USP30 (1.00) USP30
SCHEMBL20028890 0.86 USP30 (1.00) USP30
SCHEMBL29679542 0.86 USP30 (1.00) USP30
SCHEMBL29679684 0.86 USP30 (1.00) USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519397-B1 CYANO-SUBTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 MISSION THERAPEUTICS LTD (GB) 2021-05-19 EP disclosed
WO-2018060691-A1 CYANO-SUBTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 MISSION THERAPEUTICS LIMITED (GB) 2018-04-05 WO disclosed